At the same time, galectin3 expressed on MSCs can promote adhesion between MSCs and acute myeloid leukemia (AML) tumor cells by activating the MYC signaling pathway thereby promoting the survival of cancer cells [170]. The gene discussed is MYC; the disease is acute myeloid leukemia.